JPWO2023190812A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023190812A5
JPWO2023190812A5 JP2023542946A JP2023542946A JPWO2023190812A5 JP WO2023190812 A5 JPWO2023190812 A5 JP WO2023190812A5 JP 2023542946 A JP2023542946 A JP 2023542946A JP 2023542946 A JP2023542946 A JP 2023542946A JP WO2023190812 A5 JPWO2023190812 A5 JP WO2023190812A5
Authority
JP
Japan
Prior art keywords
lysine
acid
composition
glutamic acid
proline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023542946A
Other languages
English (en)
Japanese (ja)
Other versions
JP7417010B1 (ja
JPWO2023190812A1 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/013061 external-priority patent/WO2023190812A1/ja
Publication of JPWO2023190812A1 publication Critical patent/JPWO2023190812A1/ja
Application granted granted Critical
Publication of JP7417010B1 publication Critical patent/JP7417010B1/ja
Publication of JPWO2023190812A5 publication Critical patent/JPWO2023190812A5/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023542946A 2022-03-31 2023-03-30 癌免疫増強用のvipr2アンタゴニストペプチド Active JP7417010B1 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022057810 2022-03-31
JP2022057810 2022-03-31
PCT/JP2023/013061 WO2023190812A1 (ja) 2022-03-31 2023-03-30 癌免疫増強用のvipr2アンタゴニストペプチド

Publications (3)

Publication Number Publication Date
JPWO2023190812A1 JPWO2023190812A1 (https=) 2023-10-05
JP7417010B1 JP7417010B1 (ja) 2024-01-17
JPWO2023190812A5 true JPWO2023190812A5 (https=) 2024-03-08

Family

ID=88202732

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023542946A Active JP7417010B1 (ja) 2022-03-31 2023-03-30 癌免疫増強用のvipr2アンタゴニストペプチド

Country Status (2)

Country Link
JP (1) JP7417010B1 (https=)
WO (1) WO2023190812A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4137502A4 (en) * 2020-03-30 2024-02-28 Ichimaru Pharcos Co., Ltd. Vipr2 antagonist peptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4137502A4 (en) * 2020-03-30 2024-02-28 Ichimaru Pharcos Co., Ltd. Vipr2 antagonist peptide

Similar Documents

Publication Publication Date Title
US10407468B2 (en) Methods for synthesizing α4β7 peptide antagonists
US7635751B2 (en) Peptides having ligand activities on APJ that is an orphan G protein-coupled receptor, and use thereof
RU2017118326A (ru) Бициклические пептидные лиганды, специфичные для мт1-ммр
JP2015502991A5 (https=)
HUP0202367A2 (hu) FAP-aktivált tumorellenes peptidek, eljárás előállításukra, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
JP2006525288A5 (https=)
JP2026032056A5 (https=)
DK3074032T3 (en) Fatty acid derivatives of dimeric PSD-95 inhibitors
CA2295860A1 (en) Conjugates useful in the treatment of prostate cancer
EP4182023A1 (en) Inhibitors of complement factor c3 and their medical uses
JPWO2020230780A5 (https=)
JP2009544638A (ja) タンパク質結合メトトレキサート誘導体、及びそれを含有する薬剤
US6127333A (en) Conjugates useful in the treatment of prostate cancer
JP6647207B2 (ja) ヘマグルチニン結合ペプチド
JPWO2023190812A5 (https=)
JPWO2017217545A1 (ja) プレキシンの結合調節剤
JP2009518345A (ja) 因子viiiおよび因子viii様タンパク質に対する小型ペプチドおよびペプチド模倣物の親和性リガンド
JPWO2023162456A5 (https=)
TW209171B (https=)
WO2024043249A1 (ja) 環状ペプチドまたはその塩、およびmdmx阻害剤
ZA200200673B (en) Inhibitors of the integrin avbeta6.
JP2010537984A (ja) ポリペプチドおよび蛋白質の化学合成のための方法および中間体
JP2010503613A5 (https=)
US20100204449A1 (en) Methods and intermediates for chemical synthesis of polypeptides and proteins
KR102465713B1 (ko) 펩타이드 기반 일산화질소 공여체의 제조방법